There have been 50 recent insider transactions recorded for BeiGene, Ltd. (BGNE), including 14 buys and 33 sells. Total insider buying was valued at $3.13M and total insider selling at $3.6B.
Notable insiders with recent activity include Hooper Anthony C, Sharp Shalini, Brandicourt Olivier. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BGNE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-05-21 |
Hooper Anthony C |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-21 |
Sharp Shalini |
Director |
RSU Award |
10,985 |
- |
- |
19,136 |
| 2025-05-21 |
Brandicourt Olivier |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-21 |
Sanders Corazon (corsee) D. |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-21 |
Riva Alessandro |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-21 |
Dugan Margaret |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-21 |
Yi Qingqing |
Director |
RSU Award |
22,750 |
$18.19 |
$413.82K |
22,750 |
| 2025-05-13 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
200 |
$225.68 |
$45.14K |
- |
| 2025-05-09 |
Oyler John |
Chief Executive Officer |
Option Exercise (Sell) |
4,055,415 |
$0.50 |
$2.03M |
7 |
| 2025-04-14 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
365 |
$249.45 |
$91.05K |
- |
| 2025-04-01 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
5,083 |
$283.79 |
$1.44M |
- |
| 2025-03-18 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
1,107 |
$264.01 |
$292.26K |
- |
| 2025-03-14 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
- |
- |
- |
- |
| 2025-03-11 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Gift (Given) |
158,717 |
- |
- |
5,082,165 |
| 2025-03-10 |
Oyler John |
Chief Executive Officer |
Informative Sell |
700 |
$246.85 |
$172.79K |
- |
| 2025-03-07 |
Oyler John |
Chief Executive Officer |
Informative Sell |
500 |
$256.10 |
$128.05K |
- |
| 2025-03-06 |
Oyler John |
Chief Executive Officer |
Informative Sell |
100 |
$264.27 |
$26.43K |
- |
| 2025-03-05 |
Oyler John |
Chief Executive Officer |
RSU Award |
201,084 |
- |
- |
4,405,895 |
| 2025-03-05 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
200 |
$263.00 |
$52.6K |
- |
| 2025-03-05 |
Wang Lai |
Global Head of R&d |
RSU Award |
69,251 |
- |
- |
990,171 |
| 2025-03-05 |
Lee Chan Henry |
SVP, General Counsel |
RSU Award |
40,209 |
- |
- |
246,142 |
| 2025-03-05 |
Rosenberg Aaron |
Chief Financial Officer |
RSU Award |
48,581 |
- |
- |
167,128 |
| 2025-03-04 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
323 |
$257.41 |
$83.14K |
- |
| 2025-03-03 |
Oyler John |
Chief Executive Officer |
Informative Sell |
600 |
$249.25 |
$149.55K |
- |
| 2025-02-28 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
- |
- |
- |
- |
| 2025-02-27 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
1,205 |
$275.00 |
$331.38K |
- |
| 2025-02-21 |
Wang Lai |
Global Head of R&d |
Informative Sell |
400 |
$260.17 |
$104.07K |
- |
| 2025-02-21 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
100 |
$260.22 |
$26.02K |
- |
| 2025-02-20 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
21,267 |
$240.07 |
$5.11M |
- |
| 2025-02-18 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
3,159 |
$242.08 |
$764.73K |
- |
| 2025-02-04 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
1,400 |
$228.04 |
$319.26K |
- |
| 2025-01-07 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
1,301 |
$179.19 |
$233.12K |
- |
| 2024-12-14 |
Oyler John |
Chief Executive Officer |
Option Exercise |
1,300,000 |
$0.50 |
$650K |
2,978,833 |
| 2024-12-10 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
300 |
$195.67 |
$58.7K |
- |
| 2024-12-09 |
Baker Bros. Advisors Lp |
Director |
Informative Sell |
83,036 |
$186.50 |
$15.49M |
791,493 |
| 2024-12-06 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
- |
- |
- |
- |
| 2024-12-02 |
Hhlr Advisors, Ltd. |
10 Percent Owner |
Informative Sell |
17,842,500 |
$200.00 |
$3.57B |
125,045,741 |
| 2024-11-26 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Informative Sell |
883 |
$191.89 |
$169.44K |
- |
| 2024-10-08 |
Oyler John |
Chief Executive Officer |
Informative Sell |
1,452 |
$236.37 |
$343.21K |
- |
| 2024-09-30 |
Sharp Shalini |
Director |
RSU Award |
8,151 |
- |
- |
8,151 |
| 2024-09-30 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
1,202 |
$237.10 |
$284.99K |
- |
| 2024-09-27 |
Wang Lai |
Global Head of R&d |
Informative Sell |
5,000 |
$220.36 |
$1.1M |
- |
| 2024-09-27 |
Sharp Shalini |
Director |
Unknown |
- |
- |
- |
- |
| 2024-09-19 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
4,500 |
$200.14 |
$900.62K |
- |
| 2024-09-17 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
500 |
$200.00 |
$100K |
4,500 |
| 2024-09-03 |
Ball Titus B. |
Principal Accounting Officer |
Informative Sell |
137 |
$189.94 |
$26.02K |
- |
| 2024-09-03 |
Wu Xiaobin |
President, COO & GM China |
Informative Sell |
274 |
$192.04 |
$52.62K |
- |
| 2024-08-12 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
Gift (Given) |
301,457 |
- |
- |
5,266,973 |
| 2024-08-09 |
Rosenberg Aaron |
Chief Financial Officer |
RSU Award |
118,547 |
- |
- |
118,547 |
| 2024-07-30 |
Lee Chan Henry |
SVP, General Counsel |
Informative Sell |
834 |
$160.57 |
$133.92K |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
